Terms: = Prostate cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
97 results:
1. Cationic solid lipid nanoparticles (SLN) complexed with plasmid DNA enhance prostate cancer cells (PC-3) migration.
Garcia-Fossa F; de Jesus MB
Nanotoxicology; 2024 Feb; 18(1):36-54. PubMed ID: 38300021
[TBL] [Abstract] [Full Text] [Related]
2. PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axis.
Xie H; Chen J; Ma Z; Gao Y; Zeng J; Chen Y; Yang Z; Xu S
Prostate; 2024 Mar; 84(4):317-328. PubMed ID: 38145367
[TBL] [Abstract] [Full Text] [Related]
3. ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1.
Takahashi S; Takada I; Hashimoto K; Yokoyama A; Nakagawa T; Makishima M; Kume H
Sci Rep; 2023 Jul; 13(1):12355. PubMed ID: 37524814
[TBL] [Abstract] [Full Text] [Related]
4. ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in Cervical cancer.
Li QS; Zheng PS
Cancer Res; 2023 Sep; 83(18):3095-3114. PubMed ID: 37350664
[TBL] [Abstract] [Full Text] [Related]
5. GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/smad2 Signaling in prostate cancer.
Qin X; Liu L; Li Y; Luo H; Chen H; Weng X
Technol Cancer Res Treat; 2023; 22():15330338231153618. PubMed ID: 36999196
[No Abstract] [Full Text] [Related]
6. SMAD3 promotes expression and activity of the androgen receptor in prostate cancer.
Jeon HY; Pornour M; Ryu H; Khadka S; Xu R; Jang J; Li D; Chen H; Hussain A; Fazli L; Gleave M; Dong X; Huang F; Wang Q; Barbieri C; Qi J
Nucleic Acids Res; 2023 Apr; 51(6):2655-2670. PubMed ID: 36727462
[TBL] [Abstract] [Full Text] [Related]
7. Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways.
Li W; Mao Y; Hua B; Gu X; Lu C; Xu B; Pan W
Pharm Biol; 2022 Dec; 60(1):1865-1875. PubMed ID: 36205544
[TBL] [Abstract] [Full Text] [Related]
8. Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Lin HY; Ko CJ; Lo TY; Wu SR; Lan SW; Huang CA; Lin YC; Lin HH; Tu HF; Lee CF; Hsiao PW; Huang HP; Chen MJ; Chang KH; Lee MS
Oncogene; 2022 May; 41(20):2833-2845. PubMed ID: 35418692
[TBL] [Abstract] [Full Text] [Related]
9. Activation of TGF-β - smad2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK.
Natani S; Sruthi KK; Asha SM; Khilar P; Lakshmi PSV; Ummanni R
Cell Signal; 2022 Mar; 91():110240. PubMed ID: 34986386
[TBL] [Abstract] [Full Text] [Related]
10. Long non-‑coding RNA SNHG16 functions as a tumor activator by sponging miR‑373‑3p to regulate the TGF‑β‑R2/SMAD pathway in prostate cancer.
Weng W; Liu C; Li G; Ruan Q; Li H; Lin N; Chen G
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643247
[TBL] [Abstract] [Full Text] [Related]
11. Kartogenin Inhibits prostate cancer Cell Growth Through smad2 Activation and Decreases Androgen Receptor Nuclear Localization.
Takai M; Kawakami K; Fujita Y; Kato T; Kato D; Iinuma K; Koie T; Ito M; Mizutani K
Anticancer Res; 2021 Oct; 41(10):4753-4759. PubMed ID: 34593424
[TBL] [Abstract] [Full Text] [Related]
12. Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of prostate cancer Cells: Revealing Signaling Networks.
Soleymani L; Zarrabi A; Hashemi F; Hashemi F; Zabolian A; Banihashemi SM; Moghadam SS; Hushmandi K; Samarghandian S; Ashrafizadeh M; Khan H
Curr Cancer Drug Targets; 2021; 21(9):749-767. PubMed ID: 34077345
[TBL] [Abstract] [Full Text] [Related]
13. Verbascoside inhibits the epithelial-mesenchymal transition of prostate cancer cells through high-mobility group box 1/receptor for advanced glycation end-products/TGF-β pathway.
Wu CH; Chen CH; Hsieh PF; Lee YH; Kuo WW; Wu RC; Hung CH; Yang YL; Lin VC
Environ Toxicol; 2021 Jun; 36(6):1080-1089. PubMed ID: 33522686
[TBL] [Abstract] [Full Text] [Related]
14. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
[TBL] [Abstract] [Full Text] [Related]
15. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and smad2.
Li XL; Li SZ; Wu CX; Xing XH
Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530
[TBL] [Abstract] [Full Text] [Related]
16. microRNA-211-mediated targeting of the INHBA-TGF-β axis suppresses prostate tumor formation and growth.
Zhao Z; Wang K; Tan S
Cancer Gene Ther; 2021 May; 28(5):514-528. PubMed ID: 33223523
[TBL] [Abstract] [Full Text] [Related]
17. Endosulfan triggers epithelial-mesenchymal transition via PTP4A3-mediated TGF-β signaling pathway in prostate cancer cells.
Wang Y; Guo Y; Hu Y; Sun Y; Xu D
Sci Total Environ; 2020 Aug; 731():139234. PubMed ID: 32413665
[TBL] [Abstract] [Full Text] [Related]
18. Mathematical modelling of the role of Endo180 network in the development of metastatic bone disease in prostate cancer.
Ji B; Chen J; Zhen C; Yang Q; Yu N
Comput Biol Med; 2020 Feb; 117():103619. PubMed ID: 32072971
[TBL] [Abstract] [Full Text] [Related]
19. Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGFβ1/p-smad2/3 signaling.
Xu H; Sun Y; You B; Huang CP; Ye D; Chang C
Cancer Lett; 2020 Mar; 472():151-164. PubMed ID: 31846689
[TBL] [Abstract] [Full Text] [Related]
20. prostate cancer in Men With Treated Advanced Heart Failure: Should we Keep Screening?
Lee HH; Shaw NM; Mohammed S; Kowalczyk KJ; Stamatakis L; Krasnow RE
Urology; 2020 Feb; 136():46-50. PubMed ID: 31786304
[TBL] [Abstract] [Full Text] [Related]
[Next]
